Trial yields positive results for Lymphoseek

05/10/2009 | ScienceDaily

A Phase III study involving early-stage breast cancer patients showed that the radiopharmaceutical Lymphoseek can detect 100% of cancer-positive lymph nodes quicker and in a more convenient and targeted way than standard methods. "These results will really enable molecular biology to enter the operating room for lymph node detection," a researcher said.

View Full Article in:

ScienceDaily

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY